Evidence map›Paper›PMID 42146885›Full record

ReviewFrontiers in pain research (Lausanne, Switzerland)2026

Research on paclitaxel in chemotherapy-induced neuropathic pain: a bibliometric analysis integrating multiple databases.

Rui Zeng, Min Xue, Mingxia Pan, Shuang Wang, Wenxi Xie, Weihong Ge, Han Xie

Abstract readReview
In one paragraph

Review in Frontiers in pain research (Lausanne, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rui ZengDepartment of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Min XueDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.
Mingxia PanSchool of Nursing, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Shuang WangDepartment of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Wenxi XieDepartment of Pharmacy, Nanjing Drum Tower Hospital, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu, China.
Weihong GeDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.
Han XieDepartment of Pharmacy, Nanjing Drum Tower Hospital, Nanjing, Jiangsu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Paclitaxel-induced peripheral neuropathy (PIPN) significantly impairs the quality of life of cancer survivors. A systematic visualization of global research trends in this domain is currently lacking. Objective: This study aims to delineate the global research landscape, emerging hotspots, and evolutionary trends of PIPN research from Methods: Relevant literature was retrieved from Web of Science Core Collection and Scopus. Bibliometric analyses, including co-occurrence and thematic evolution, were performed using VOSviewer and CiteSpace. Results: A total of Conclusion: PIPN research is rapidly expanding, moving from phenomenological observation to mechanistic elucidation and holistic management. Future directions include precision medicine and comprehensive biopsychosocial interventions.

Indexed as

bibliometric analysischemotherapy-induced peripheral neuropathyCIPNcitespacepaclitaxel-induced neuropathic painresearch trendsVOSviewer

Identifiers

PMID42146885
PMCPMC13171559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.